Mark Cuban: AI Could Worsen Health in the USA

Mark Cuban and the Potential Impact of AI on the American Healthcare System

Mark Cuban, the renowned entrepreneur and investor, recently expressed his concerns regarding the use of artificial intelligence (AI) in the American healthcare system. According to him, AI could transform this sector into a true battleground between insurers and hospitals. Cuban envisions a scenario where insurers use AI to protect their profit margins, while hospitals leverage it to contest denial of reimbursement decisions. He compares this situation to a comic strip where two rival spies are constantly trying to outdo and sabotage each other.

For those who hoped that AI would solve the problems of the American healthcare system, Cuban suggests revisiting that perspective. While he acknowledges that AI can assist doctors, he warns against its exploitation by insurers and other healthcare intermediaries, who could complicate and burden care for both doctors and patients.

"For every future agent we give to doctors to face this friction and improve the quality of care, the conglomerates will have multiple adversarial agents doing everything they can to delay and deny," Cuban wrote in a post on X on Sunday.

Cuban's statement followed a comment from venture capitalist Marc Andreessen, who claimed that "AI is already a better doctor than 99.99% of human doctors." Cuban emphasized that the main obstacle to improving healthcare lies with insurers, pharmacy benefit managers, and other intermediaries, who, according to him, already monopolize a significant portion of doctors' time and have every incentive to use AI to preserve their profits.

"25% or more of a doctor's time is spent dealing with conglomerates that do everything they can to make doctors' care more difficult and costly, both for the doctor and the patient," he wrote.

An AI Conflict Already Present in the Healthcare Sector

Cuban asserts that this conflict over AI is already underway in the healthcare sector. He describes how conglomerates use AI to exploit contracts and circumvent rules, while hospitals hire companies specializing in revenue cycle management, which take up to 10% of revenues for their agents to attempt to counter these practices.

Cuban has long criticized the role of intermediaries in driving up healthcare costs. In 2022, he co-founded Cost Plus Drug Company, a venture aimed at reducing prescription drug prices by eliminating traditional intermediaries and selling generic medications directly to consumers with transparent margins.

He likens competing AI agents to "the agentic version of Mad magazine's Spy vs. Spy," a comic strip where two rival spies are constantly trying to outdo and sabotage each other.

Cuban also points out that employers lack visibility into the actual costs of healthcare, complicating the optimization of spending through AI.

"There is not a single company, including yours, that knows the true cost of the care it is purchasing for your employees and their families. Not one," he wrote on X.

Rather than adding a layer of AI to the existing healthcare system, Cuban suggests that companies should use AI agents to negotiate and contract directly with care providers, thereby bypassing insurers and other intermediaries. Until these intermediaries are eliminated, he stated, AI alone will not solve the industry's biggest problems.